353 filings
Page 8 of 18
8-K
08vayhrqdc1jmme0u7
9 Jun 14
Robert E. Conway Elected Chairman of Arca Biopharma
12:00am
8-K
2keaa8m ww
3 Mar 14
Departure of Directors or Certain Officers
12:00am
8-K
mtl3wlbfsnjzm
18 Feb 14
Departure of Directors or Certain Officers
12:00am
8-K
m440ym
12 Feb 14
Dan Mitchell Joins Arca Biopharma Board of Directors
12:00am
8-K
o347fkh2ic322yoqq
4 Feb 14
Arca Biopharma Announces Proposed Public Offering of Common Stock and Warrants
12:00am
8-K
c5stzccmiudyzm8u
8 Jan 14
Arca Biopharma to Present at Biotech Showcase 2014
12:00am
8-K
36ec9ky3
5 Dec 13
Arca Biopharma Announces Us Fda Acceptance of Gencaro Ind
12:00am
8-K
yhe0xc35
21 Nov 13
Arca Biopharma Announces Resignation from Board of Directors
12:00am
8-K
y3dcxd 7dl4
6 Nov 13
Entry into a Material Definitive Agreement
12:00am
8-K
gfh6r
29 Oct 13
Arca Biopharma Announces Ind Submission to Us Fda for Gencaro
12:00am
8-K
4oxgewdnafz 6o3w61
23 Sep 13
Departure of Directors or Certain Officers
12:00am
8-K
l1qjy
4 Sep 13
Robert E. Conway Appointed to Arca Biopharma Board of Directors
12:00am
8-K
0rsvhj
6 Aug 13
Entry into a Material Definitive Agreement
12:00am
8-K
65mm3571na8 i2d2zyib
30 Jul 13
Raymond L. Woosley, M.D., PH.D. Appointed to Arca Biopharma Board of Directors
12:00am
8-K
912k zs9598k81bz8uy7
25 Jul 13
ARCA biopharma Announces Additions to GENETIC-AF Leadership Team
12:00am
8-K
g5m knkwqy1o
18 Jul 13
Arca Biopharma Provides Business Update
12:00am
8-K
71qhm21k5f3
1 Jul 13
Regulation FD Disclosure
12:00am
8-K
j988zg78ev
18 Jun 13
Departure of Directors or Certain Officers
12:00am
8-K
j3l26cibgukj8u 2x5
6 Jun 13
Pharmacogenetic Enhancement of Effectiveness for Prevention of Atrial
12:00am
8-K
k7f3yhz
30 May 13
Arca Biopharma Announces Pricing of $20 Million Equity Offering
12:00am